DR. SUSAN JANE KNOX, M.D.,PH.D.
Radiology in Palo Alto, CA
License number
California G58623
Category
Radiology
Type
Radiation Oncology
Address
Address
875 Blake Wilbur Dr Dept. Radiation Oncology - Cancer Ctr, Palo Alto, CA 94304
Phone
(650) 723-6171
(650) 725-8231 (Fax)
(650) 725-2720
(650) 723-7254 (Fax)
(650) 725-8231 (Fax)
(650) 725-2720
(650) 723-7254 (Fax)
Organization information
See more information about SUSAN JANE KNOX at bizstanding.comSusan Jane Knox
731 San Rafael Pl, Palo Alto, CA 94305
Status:
Inactive
Industry:
Business Services at Non-Commercial Site
Principal:
Susan J. Knox Principal, inactive
Professional information
Dr. Susan J Knox, Fremont CA - MD (Doctor of Medicine)
Specialties:
Radiation Oncology
Address:
3200 Kearney St, Fremont 94538
(510) 490-1222 (Phone)
Stanford University Medical Center RDO
875 Blake Wilbur Dr STE G224, Palo Alto 94304
(650) 723-6171 (Phone)
(510) 490-1222 (Phone)
Stanford University Medical Center RDO
875 Blake Wilbur Dr STE G224, Palo Alto 94304
(650) 723-6171 (Phone)
Languages:
English
Hospitals:
3200 Kearney St, Fremont 94538
Stanford University Medical Center RDO
875 Blake Wilbur Dr STE G224, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Stanford University Medical Center RDO
875 Blake Wilbur Dr STE G224, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1985
Stanford University Hospital
University Ca Davis Med Center
Stanford University School Of Medicine
Graduated: 1985
Stanford University Hospital
University Ca Davis Med Center
Susan Jane Knox, Stanford CA
Specialties:
Radiology, Radiation Oncology, Medical Oncology
Work:
Radiation Therapy Department
875 Blake Wilbur Dr, Stanford, CA 94305
875 Blake Wilbur Dr, Stanford, CA 94305
Education:
Stanford University (1985)
Susan Jane Knox, Palo Alto CA
Specialties:
Oncologist
Address:
875 Blake Wilbur Dr, Palo Alto, CA 94304
O-Nitro Compounds, Pharmaceutical Compositions Thereof And Uses Thereof
US Patent:
2007013, Jun 14, 2007
Filed:
Aug 11, 2006
Appl. No.:
11/502974
Inventors:
Mark Bednarski - Los Altos CA, US
Lynn Oehler - Los Altos CA, US
Susan Knox - Stanford CA, US
Louis Cannizzo - Ogden UT, US
Kirstin Warner - Ogden UT, US
Robert Wardle - Ogden UT, US
Stephen Velarde - North Ogden UT, US
Shoucheng Ning - Palo Alto CA, US
Lynn Oehler - Los Altos CA, US
Susan Knox - Stanford CA, US
Louis Cannizzo - Ogden UT, US
Kirstin Warner - Ogden UT, US
Robert Wardle - Ogden UT, US
Stephen Velarde - North Ogden UT, US
Shoucheng Ning - Palo Alto CA, US
Assignee:
RadioRx, Inc. - Menlo Park CA
Alliant Techsystems Inc. - Edina MN
Alliant Techsystems Inc. - Edina MN
International Classification:
A61K 31/69, C07D 331/02, A61K 31/21
US Classification:
514064000, 514509000, 514114000, 514475000, 514430000, 549001000, 558454000, 549546000
Abstract:
The present invention provides O-nitro compound, pharmaceutical compositions of O-nitro compounds and methods of using O-nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
Cyclic Nitro Compounds, Pharmaceutical Compositions Thereof And Uses Thereof
US Patent:
2007013, Jun 14, 2007
Filed:
Aug 11, 2006
Appl. No.:
11/502810
Inventors:
Mark Bednarski - Los Altos CA, US
Susan Knox - Stanford CA, US
Louis Cannizzo - Ogden UT, US
Kirstin Warner - Ogden UT, US
Robert Wardle - Ogden UT, US
Stephen Velarde - North Ogden UT, US
Shoucheng Ning - Palo Alto CA, US
Lynn Oehler - Los Altos CA, US
Susan Knox - Stanford CA, US
Louis Cannizzo - Ogden UT, US
Kirstin Warner - Ogden UT, US
Robert Wardle - Ogden UT, US
Stephen Velarde - North Ogden UT, US
Shoucheng Ning - Palo Alto CA, US
Lynn Oehler - Los Altos CA, US
Assignee:
RadioRx, Inc. - Menlo Park CA
Alliant Techsystems Inc. - Edina CA
Alliant Techsystems Inc. - Edina CA
International Classification:
A61K 31/675, C07D 205/02, A61K 31/397
US Classification:
514079000, 514210170, 548953000
Abstract:
The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
Methods For Treating A Neoplastic Disease In A Subject Using Inorganic Selenium-Containing Compounds
US Patent:
2007016, Jul 12, 2007
Filed:
Nov 12, 2004
Appl. No.:
10/576568
Inventors:
Susan Knox - Stanford CA, US
Bryan Husbeck - Palo Alto CA, US
Bryan Husbeck - Palo Alto CA, US
International Classification:
A61K 33/04
US Classification:
424702000
Abstract:
The invention features methods and selenium-containing compositions for treating a neoplastic disease in a subject. In particular, the invention features methods for enhancing sensitivity of a tumor to cancer therapy by treating the tumor with an inorganic selenium-containing (iSe) compound and with a cancer therapy, particularly a cancer therapy that also affects the cellular redox status of a tumor cell (e.g., radiation).
X-Nitro Compounds, Pharmaceutical Compositions Thereof And Uses Thereof
US Patent:
2009029, Nov 26, 2009
Filed:
Apr 23, 2009
Appl. No.:
12/429093
Inventors:
Mark D. BEDNARSKI - Los Altos CA, US
Lynn M. Oehler - Los Altos CA, US
Andrew C. Haaland - Park City UT, US
Susan J. Knox - Stanford CA, US
Lynn M. Oehler - Los Altos CA, US
Andrew C. Haaland - Park City UT, US
Susan J. Knox - Stanford CA, US
Assignee:
RadioRx, Inc. - Menlo Park CA
International Classification:
A61K 31/397
US Classification:
51421001
Abstract:
The present invention provides X-nitro compound, pharmaceutical compositions of X-nitro compounds and methods of using X-nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
Catheter System For Minimizing Retrograde Bacterial Transmission From A Catheter Tubing
US Patent:
2007016, Jul 12, 2007
Filed:
Jan 6, 2006
Appl. No.:
11/327835
Inventors:
Susan Knox - Stanford CA, US
Caroline Schore - Davis CA, US
Caroline Schore - Davis CA, US
International Classification:
A61M 31/00, A61M 37/00
US Classification:
604093010
Abstract:
The present invention provides systems and methods for minimizing the retrograde transmission from the catheter tubing. The invention is particularly suitable for reducing the likelihood of a patient acquiring a urinary tract infection associated with an indwelling catheter. The systems and methods include a catheter tubing having a proximal and distal end with a filter located therebetween and a means for accessing negative pressure for creating a pressure differential between the proximal and distal ends of the catheter tubing.
Cyclic Nitro Compounds, Pharmaceutical Compositions Thereof And Uses Thereof
US Patent:
8299053, Oct 30, 2012
Filed:
Mar 4, 2009
Appl. No.:
12/397651
Inventors:
Mark D. Bednarski - Los Altos CA, US
Susan Knox - Stanford CA, US
Louis Cannizzo - Ogden UT, US
Kirstin Warner - Ogden UT, US
Robert Wardle - Ogden UT, US
Stephen Velarde - North Ogden UT, US
Shoucheng Ning - Palo Alto CA, US
Susan Knox - Stanford CA, US
Louis Cannizzo - Ogden UT, US
Kirstin Warner - Ogden UT, US
Robert Wardle - Ogden UT, US
Stephen Velarde - North Ogden UT, US
Shoucheng Ning - Palo Alto CA, US
Assignee:
RadioRx, Inc. - Menlo Park CA
Alliant Techsystems Inc. - Minneapolis MN
Alliant Techsystems Inc. - Minneapolis MN
International Classification:
A61K 31/397, C07D 205/04
US Classification:
51421017, 548953
Abstract:
The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
Organonitro Compounds For Use In Treating Non-Hodgkin's Lymphoma And Leukemia, And Methods Relating Thereto
US Patent:
2012014, Jun 14, 2012
Filed:
Dec 9, 2011
Appl. No.:
13/315888
Inventors:
Bryan T. Oronsky - Los Altos Hills CA, US
Susan Knox - Stanford CA, US
Jan Scicinski - Saratoga CA, US
Shoucheng Ning - Santa Clara CA, US
Susan Knox - Stanford CA, US
Jan Scicinski - Saratoga CA, US
Shoucheng Ning - Santa Clara CA, US
International Classification:
A61K 31/397, A61K 31/4468, A61K 31/12, A61K 31/16, A61K 31/04, A61P 35/02, A61K 31/445, A61K 31/255, A61K 31/22, A61K 31/40, A61P 35/00
US Classification:
51421017, 514423, 514315, 514676, 51421001, 514426, 514628, 514517, 514518, 514550, 514742, 514740
Abstract:
The invention provides organonitro compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat non-Hodgkin's lymphoma and certain leukemias in a patient. The compounds, compositions, kits, and methods are contemplated to provide a therapeutic benefit in treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia, acute myelogenous leukemia, chronic myelogenous leukemia, and acute lymphoblastic leukemia. Exemplary organonitro compounds described herein include alkyl-substituted and acyl-substituted di-nitroheterocycles.